Shiver your way to better blood sugar? new study tests cold therapy for diabetes
NCT ID NCT05576025
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether shivering from cold exposure can improve 24-hour blood sugar levels in people with prediabetes or type 2 diabetes. Twenty-four participants underwent two cold sessions at different shivering intensities. The goal was to see if muscle activation from shivering helps the body use glucose better. It is a small, early-stage study, so results are not yet conclusive.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cold exposure (shivering at different intensities)
- What this could lead to
- If it works, this could point toward a simple, drug-free way to help manage blood sugar in type 2 diabetes or prediabetes.
- What could go wrong
- This is a very small, early study (24 people) looking at short-term effects only. The results may not lead to a practical treatment, and cold exposure may be uncomfortable or risky for some.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
24 people
The number who actually took part.
- Started
-
Nov 2022
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Inclusion criteria for all subjects: * to be able to provide signed and dated written informed consent prior to any study specific procedures * have suitable veins for cannulation or repeated venepuncture * male, or postmenopausal (at least 1 year post cessation of menses) female * aged 40 - 75 years * have stable dietary habits (no weight loss or gain \>5 kg within the past 3 months) * have no signs of active cardiovascular disease or liver malfunction * have body mass index (BMI) \>= 27 and \<= 38 kg/m2 Additional inclusion criteria for pre-diabetic subjects: Pre-diabetes based on one or a combination of the following criteria: * Impaired Glucose Tolerance (IGT): plasma glucose values ≥ 7.8 mmol/l and ≤ 11.1 mmol/l 120 minutes after glucose drink consumption during OGTT in screening * ImpairedFastingGlucose(IFG):Fastingplasmaglucose≥6.1mmol/land≤6.9 mmol/l * Insulin Resistance: glucose clearance rate ≤ 360 mL/kg/min, as determined using OGIS120 * HbA1c of 5.7-6.4% Additional inclusion criteria for type 2 Diabetes Mellitus patients: * being diagnosed with T2DM at least 1.5 years before the start of the study * have well-controlled diabetes, i.e. HbA1c levels \< 8.5% * have no signs of active diabetes-related co-morbidities, including active cardiovascular diseases, diabetic foot, polyneuropathy or retinopathy * diet treatment OR on an oral glucose lowering medication: metformin only or in combination with sulfonylurea agents and/or on stable dose of a DPPIV inhibitor treatment for at least the last 3 months Exclusion Criteria: * not meeting the respective inclusion criteria * participation in a clinical study with an investigational product during the last 3 months or as judged by the investigator * uncontrolled hypertension * having Hb \<8 mmol/L (men), Hb \<7 mmol/l (women) * consuming alcohol \>2 servings per day (man) or \>1 servings per day (women) * not wanting to be informed about unexpected medical findings during the screening * being engaged in structured exercise \> 2h per week * smoking * being cold-acclimated, e.g. having taken daily extended cold baths, working in a refrigerated environment, or practicing regular cold-water swimming/showering within 1 month of starting the study Exclusion criteria specific for pre-diabetic subjects: \- Type 2 Diabetes Mellitus Exclusion criteria specific for type 2 Diabetes Mellitus patients: \- being insulin-dependent and/or using SGLT2 inhibitor medications
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pre-diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maastricht University, Department of Nutrition and Movement Sciences
Maastricht, Limburg, 6200MD, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heartbeat test aims to catch hidden nerve damage in diabetes
- Can Home-Delivered meals help control diabetes?
- New pill takes aim at stubborn blood sugar
- Gene therapy shots aim to save legs from amputation in diabetes
- New pill takes aim at blood sugar in diabetes
- Can an AI chatbot coach people away from type 2 diabetes?